Cutler Group LP Mesoblast LTD Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$3.58 - $4.98 $1,886 - $2,624	-527 Reduced 25.55%	1,536 $6,000
Q4 2021 Jan 18, 2022	SELL	$4.17 - $7.09 $233 - $397	-56 Reduced 2.64%	2,063 $9,000
Q3 2021 Oct 26, 2021	SELL	$5.87 - $7.85 $4,109 - $5,495	-700 Reduced 24.83%	2,119 $12,000
Q2 2021 Jul 19, 2021	BUY	$6.69 - $9.0 $13,507 - $18,171	2,019 Added 252.38%	2,819 $21,000
Q1 2021 Apr 26, 2021	SELL	$8.26 - $11.4 $25,606 - $35,340	-3,100 Reduced 79.49%	800 $6,000
Q4 2020 Jan 21, 2021	SELL	$8.21 - $18.59 $6,568 - $14,872	-800 Reduced 17.02%	3,900 $33,000
Q3 2020 Oct 27, 2020	BUY	$11.33 - $19.81 $30,591 - $53,487	2,700 Added 135.0%	4,700 $87,000
Q2 2020 Jul 22, 2020	SELL	$4.2 - $15.45 $5,460 - $20,085	-1,300 Reduced 39.39%	2,000 $22,000
Q1 2020 May 07, 2020	BUY	$3.38 - $10.63 $11,154 - $35,079	3,300 New	3,300 $14,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.